Effects of acute administration of a prostaglandin E2 analog, trimoprostil, on esophageal motility in man. 1987

G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer

The effect of trimoprostil, and oral trimethyldesoxy prostaglandin E2 analog with antisecretory and cytoprotective activity, on esophageal motility was evaluated in a double-blind, three-way crossover study. Using antisecretory and cytoprotective single oral doses, 0.75 and 1.5 mg of trimprostil was compared with placebo in 12 healthy male volunteers. Motility parameters measured included lower esophageal sphincter pressure, amplitude, velocity, and duration of esophageal contractions. Unlike most previously reported prostaglandin E2 infusion studies, our study demonstrated that oral trimoprostil at low or high doses, when compared with placebo, had no effect on lower esophageal sphincter pressure or distal esophageal peristaltic amplitude in response to wet swallows. Therefore, oral administration of methylated prostaglandin E2 analogs would not be expected to contribute to esophageal reflux.

UI MeSH Term Description Entries
D008297 Male Males
D011312 Pressure A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Pressures
D011459 Prostaglandins E, Synthetic Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE. PGE Synthetic,Prostaglandin E Analogs,Prostaglandin E Analogues,Synthetic Prostaglandins E,Analogs, Prostaglandin E,Analogues, Prostaglandin E,Synthetic, PGE
D004943 Esophagogastric Junction The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice. Gastroesophageal Junction,Gastroesophageal Junctions,Junction, Esophagogastric,Junction, Gastroesophageal,Junctions, Gastroesophageal
D004947 Esophagus The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
D005769 Gastrointestinal Motility The motor activity of the GASTROINTESTINAL TRACT. Intestinal Motility,Gastrointestinal Motilities,Intestinal Motilities,Motilities, Gastrointestinal,Motilities, Intestinal,Motility, Gastrointestinal,Motility, Intestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
September 1975, Journal of applied physiology,
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
March 1986, Arzneimittel-Forschung,
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
February 1993, Medizinische Klinik (Munich, Germany : 1983),
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
February 1987, European journal of clinical investigation,
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
June 1985, Digestive diseases and sciences,
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
August 1988, Clinical pharmacology and therapeutics,
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
January 1987, Minerva dietologica e gastroenterologica,
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
October 1979, Deutsche medizinische Wochenschrift (1946),
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
August 1977, Experientia,
G J Schwartz, and R A Levine, and S Petokas, and H E Gallo-Torres, and M L Scheinbaum, and J M Sondheimer
November 1988, Gastroenterologie clinique et biologique,
Copied contents to your clipboard!